The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary Total Hip Arthoplasty:

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDiakonie-Klinikum Stuttgart

About this trial

The aim of this study is to investigate the analgesic efficacy of the pericapsular nerve group (PENG) block during the implantation of hip endoprostheses. The study is designed as a prospective randomized double-blind study and the study participants were randomized into 2 arms and either 20 ml ropivacaine 0.5% (verum group) or 20 ml physiological saline solution (placebo group) will be applied.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

planned cementless hip TEP operation for primary coxarthrosis via minimally invasive anterolateral approach using the identical implant system (Taperloc stem, Plamafit cup)

Patient capable of giving consent

Informed consent has been obtained

age > 18 years

Disqualifiers

Refusal to participate in the study

Regular use of opioids

Known chronic pain symptoms

Infections in the area of the puncture site

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ropivacaine

    Drug

    PENG block with ropivacaine

  • Physiological saline

    Other intervention

    Placebo control

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: Verum GroupExperimental treatment 1 intervention
Group B: Placebo GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Rate of postoperative opioid administration

The primary objective is to investigate the influence of the PENG block on the need for postoperative ntravenously opioid administration within the first hour in the recovery room.

Time frame
60 minutes after arrival in the recovery room

Secondary outcomes

1

Quantity of total opioid consumption

Assessment of total opioid consumption until second postoperative day in both arms

Time frame
until the evening of the second postoperative day
2

Intensity of postoperative pain

Subjective perception of postoperative pain, using the numeric rating scale.

Time frame
until the evening of the second postoperative day
3

Intensity of postoperative nausea and vomiting

Assessment of postoperative nausea/vomiting using the PONV Score

Time frame
until the evening of the second postoperative day
4

Postoperative recovery

Assessment of postoperative recovery using the QoR15 score

Time frame
until the evening of the second postoperative day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Diakonie-Klinikum Stuttgart

Lead sponsor

University Hospital Tuebingen

Collaborator